Biotech experts, top LSD researchers, science specialists, influencers, and medical professionals are invited to attend the virtual LSD Conference being held on February 17, 2022. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers focused on the research regarding therapeutic benefits and potential of LSD.
The conference is organized by Microdose, a premier organization engaged in creating, offering and distributing the most compelling content on the finance, industry news, science, and the latest breakthroughs and events of the psychedelic industry. This is the biggest platform offering exposure to professionals, companies, and individuals about the events of the psychedelic industry.
The title sponsor of the virtual event is MindBio Therapeutics, a clinical-stage drug development company engaged in the research of microdosing and the medicinal benefits of psychedelic medicines in treating debilitating mental illnesses.
This 2-day virtual event will explore the scope and potential of LSD along with discussing the latest innovations in drug development, clinical safety and care, the laws and regulations, science and research, culture and creativity, as well as business trends.
This LSD event offers a phenomenal platform and a huge breadth of audience. The attendees can interact with industry influencers and organizations who will discuss the future potential of LSD in different sectors. They will learn the varied uses of LSD and its potential non-psychedelic uses, its role in healing debilitating mental conditions, drug development and safety, clinical applications, and its creative effects, to name a few. This conference is a great networking medium where businesses and professionals can connect to build relationships and explore the latest innovations in psychedelic science.
The major points of discussion at the conference include:
- Therapeutic Use of LSD in Psychiatry
- Posology and Tolerance to Regression
- Safety and Efficacy of Lysergic Acid Diethylamide Assisted Psychotherapy
- LSD Microdosing
- Effect of Lysergic Acid Diethylamide (“LSD”) on Learning
- The Effects of LSD on Creativity
Attendees buying tickets to the event can attend the sessions, live presentations, group discussions as well as avail networking opportunities in one-to-one meetings with dedicated companies. Also, they will have lifetime access to the live recordings and will be added to the My content section of the website of every ticketholder’s account within 5 business days following the event.
For more information visit https://nnw.fm/wi29E.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
No comments:
Post a Comment